Jeremy R. MacKechnie - 29 Mar 2022 Form 4 Insider Report for Starry Group Holdings, Inc.

Role
Executive Vice President, Head of People and Customer Experience
Signature
/s/ William Lundregan, attorney-in-fact
Issuer symbol
N/A
Transactions as of
29 Mar 2022
Net transactions value
$0
Form type
4
Filing time
31 Mar 2022, 16:05:01 UTC
Previous filing
28 Mar 2022
Next filing
06 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STRY Stock Option (Right to Buy) Award +82,835 82,835 29 Mar 2022 Class A Common Stock 82,835 $0.4200 Direct F1, F2
transaction STRY Stock Option (Right to Buy) Award +9,203 9,203 29 Mar 2022 Class A Common Stock 9,203 $1.74 Direct F1, F2
transaction STRY Stock Option (Right to Buy) Award +27,611 27,611 29 Mar 2022 Class A Common Stock 27,611 $1.74 Direct F1, F3
transaction STRY Stock Option (Right to Buy) Award +18,407 18,407 29 Mar 2022 Class A Common Stock 18,407 $2.88 Direct F1, F4
transaction STRY Stock Option (Right to Buy) Award +46,019 46,019 29 Mar 2022 Class A Common Stock 46,019 $7.99 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to the Agreement and Plan of Merger, dated as of October 6, 2021 (as the same has been or may be amended, modified, supplemented or waived from time to time, the "Merger Agreement") by and among FirstMark Horizon Acquisition Corp., Sirius Merger Sub, Inc., Starry, Inc. ("Starry"), and Starry Group Holdings, Inc. (the "Issuer"), each outstanding Starry equity award was converted into a corresponding equity award of the Issuer, on the same terms and conditions as were applicable to the Starry equity award, based on the applicable exchange ratio (determined in accordance with the Merger Agreement).
F2 The option is fully vested and exercisable.
F3 The option vested and became exercisable as to 25% of the underlying shares on December 3, 2019, and the remainder has vested and will continue to vest in 36 substantially equal monthly installments thereafter.
F4 The option vested and became exercisable as to 25% of the underlying shares on February 28, 2021, and the remainder has vested and will continue to vest in 36 substantially equal monthly installments thereafter.
F5 The option vests and becomes exercisable as to 25% of the underlying shares on July 30, 2022, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter.

Remarks:

Executive Vice President, Head of People and Customer Experience